|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.360 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 50,476 | 36,210 | (135,335) | 26,204 | 47,765 |
| Net Cash from / (used in) Investing Activities | (22,140) | 4,530 | 257,814 | 595,602 | (206,875) |
| Net Cash from / (used in) Financing Activities | (28,972) | (46,676) | (124,798) | (624,245) | 101,373 |
| Increase / (Decrease) in Cash & Cash Equivalents | (636) | (5,936) | (2,319) | (2,439) | (57,737) |
| Cash & Cash Equivalents at beginning of period | 1,916 | 4,364 | 3,317 | 28,198 | 87,793 |
| Effect of Foreign Exchange Rate Changes | 240 | 3,488 | 3,366 | (17,923) | (1,858) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 1,520 | 1,916 | 4,364 | 7,836 | 28,198 |
| Remarks: | Real time quote last updated: 16/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -18,433 |
| %Change | 9.032% |
| EPS / (LPS) | RMB -0.022 |
| NBV Per Share (¥) | RMB -0.117 |